BridgeMD
Tests treatment safety and results for Joint Health
Official title A Decentralized Clinical Study Evaluating the Effectiveness of Two Different Doses of MyCondro™ on Physical Mobility and Joint Health
ClinicalTrials.gov ID: NCT07493239
What this study is testing
- What it's testing
- This study evaluates the effect of two different doses of a consumer-grade product, MyCondro™, on individuals experiencing mobility issues related to knee osteoarthritis. The primary goal is to measure improvements in overall joint health and mobility by tracking changes in participants' total WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scores from the beginning to the end of the trial.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 and older. Healthy volunteers may be eligible.
You may be able to join if
- Individuals age 45 years and older.
- BMI range between 18-35 kg/m².
- Self-reported mobility issues, including mobility impairment and joint discomfort associated with a known diagnosis of Knee Osteoarthritis. This...
- Willingness to avoid high Chondroitin Sulfate-containing foods (i.e., animal cartilages, bones, or derivatives such as gelatin) for the duration of...
- Willingness to refrain from supplements containing Chondroitin Sulfate for the duration of the study period.
You likely can't join if
- Any potential participants will be excluded if they meet any of the following criteria:
- Technology Limitation: Do not have a personal smartphone, lack internet access, or are unwilling to download the Chloe app.
- Concomitant Therapies
- Use of a Chondroitin Sulfate supplement in the 3 months prior to randomization.
- Current use of other joint health supplements (e.g., glucosamine, hyaluronic acid, collagen peptides) for at least 4 weeks prior to randomization.
- Use of any intra-articular or intravenous steroid injections in the last 3 months.
See the full eligibility criteria
- Individuals age 45 years and older.
- BMI range between 18-35 kg/m².
- Self-reported mobility issues, including mobility impairment and joint discomfort associated with a known diagnosis of Knee Osteoarthritis. This impairment and discomfort must have persisted for at least 6 months prior...
- Willingness to avoid high Chondroitin Sulfate-containing foods (i.e., animal cartilages, bones, or derivatives such as gelatin) for the duration of the study period.
- Willingness to refrain from supplements containing Chondroitin Sulfate for the duration of the study period.
- Able to read and understand English.
- Able to read, understand, and provide informed consent.
- Able to use a personal smartphone device and download the Chloe by People Science app.
- Able to receive shipments of the product at an address within the United States.
- Able to complete study assessments over the course of up to 16 weeks.
- Any potential participants will be excluded if they meet any of the following criteria:
- Technology Limitation: Do not have a personal smartphone, lack internet access, or are unwilling to download the Chloe app.
- Concomitant Therapies
- Use of a Chondroitin Sulfate supplement in the 3 months prior to randomization.
- Current use of other joint health supplements (e.g., glucosamine, hyaluronic acid, collagen peptides) for at least 4 weeks prior to randomization.
- Use of any intra-articular or intravenous steroid injections in the last 3 months.
- Receiving any investigational therapies or treatments within 30 days prior to randomization. Other Illnesses or Conditions
- Self-reported inflammatory arthropathies, such as Rheumatoid Arthritis, Gout, and Infectious Arthritis.
- Significant systemic lung, liver, heart, or kidney disease (excluding hypertension).
- Prior history of knee surgery within 3 months preceding the study period, or planned knee surgery (including arthroscopy) during the study period.
- Currently diagnosed with Alcohol Use Disorder and/or Substance Use Disorder.
- Currently pregnant, planning to become pregnant in the next 20 weeks, or breastfeeding.
- Presence of a knee prosthesis.
- Any significant illness, disease, or condition which, in the opinion of the Principal Investigator, may impact the ability to participate in the study or impact the study outcomes. Allergies and Intolerances
- Known hypersensitivity or previous allergic reaction to: Chondroitin sulfate, Maltodextrin, Mannitol, Magnesium Stearate, Silicon dioxide, Microcrystalline cellulose, or Talc.
- Known sensitivity or intolerance to wheat or gluten. General Compliance 1- Unlikely for any reason to be able to comply with the trial, or considered unsuited for participation in the study by the Principal Investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.